NCT06217783

Brief Summary

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Mar 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Mar 2024Dec 2027

First Submitted

Initial submission to the registry

January 10, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

March 27, 2024

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

3.7 years

First QC Date

January 10, 2024

Last Update Submit

December 16, 2025

Conditions

Oncologic Complications and Emergencies

Outcome Measures

Primary Outcomes (1)

  • Safety and adverse events (AEs)

    Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)

    Through study completion; an average of 1 year.

Study Arms (2)

Group A

EXPERIMENTAL

Participants will receive a catheter that is up to 1.75 inches long based on what the nurse thinks is best for you.

Device: Introcan Safety IV Catheter

Group B

EXPERIMENTAL

Participants will receive a catheter that is either 1.75 or 2.5 inches long based on what the nurse thinks is best for you.

Device: Introcan Safety IV Catheter

Interventions

Introcan Safety IV CatheterDEVICE

Given by IV

Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years old.
  • Provision of signed and dated informed consent form.
  • Predetermined to have difficult IV access necessitating USIV placement
  • Expected admission to hospital with anticipated stay \> 48 hours (per discussion with treating physician).

You may not qualify if:

  • Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
  • Inability to give informed consent.
  • Pregnant women.
  • Non-English speaking participants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jonathan Rowland, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jonathan Rowland, MD

CONTACT

(832) 450-8954jwrowland@mdanderson.org

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2024

First Posted

January 22, 2024

Study Start

March 27, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

December 18, 2025

Record last verified: 2025-12

Locations

US(1)